Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Odyssey Therapeutics, Inc. | 62,908 | reported | 08 May 2026 | tx 1+1,000 |
| LIGAND PHARMACEUTICALS INC | 6,606 | reported | 06 Jun 2025 | tx 8+27,948 |
| Syros Pharmaceuticals, Inc. | 0 | reported | 18 Nov 2024 | tx 24+1,237,583−210,166 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 May 2026 | PURCHASE | Odyssey Therapeutics, Inc. | 1,000 | 20.00 USD | first after silence |
| 06 Jun 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,209 | 0.00 USD | |
| 06 Jun 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5,783 | 0.00 USD | deriv |
| 18 Nov 2024 | SALE | Syros Pharmaceuticals, Inc. | 137,803 | 0.21 USD | |
| 31 Oct 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 5,624 | 2.09 USD | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | — | |
| 31 Oct 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | 0.00 USD | deriv |
| 11 Sept 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 19,293 | 1.58 USD | |
| 12 Sept 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 45,344 | 1.68 USD | |
| 10 Sept 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 35,363 | 1.55 USD | |
| 14 Jun 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,252 | 0.00 USD | |
| 14 Jun 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5,444 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13,333 | — | |
| 01 Apr 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4,732 | 5.12 USD | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13,333 | 0.00 USD | deriv |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | — | |
| 01 Nov 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6,301 | 2.22 USD | |
| 31 Oct 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18,875 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,142 | 0.00 USD | |
| 09 Jun 2023 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5,461 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | — | |
| 03 Apr 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 Mar 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 May 2026.